Vetmedin Solution is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. It is protected by 8 US drug patents filed from 2025 to 2037. Out of these, 7 patents are active and 1 patent has expired. Details of Vetmedin Solution’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US10071162 | 18 Sep, 2034 | Active |
| US9463199 | 27 Apr, 2029 | Active |
| US11185590 | 05 Nov, 2028 | Active |
| US12357696 | 05 Nov, 2028 | Active |
| US8980894 | 12 Apr, 2026 | Active |
| US9889148 | 23 Mar, 2025 | Expired |
Exclusivity Information
Vetmedin Solution holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2029. Details of Vetmedin Solution's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Jan 15, 2029 |
About Vetmedin Solution
Vetmedin Solution is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Vetmedin Solution uses
Pimobendan as the active
ingredient.
Active Ingredient:
Vetmedin Solution uses
Pimobendan as the active ingredient.
Check out other Drugs and Companies using
Pimobendan ingredient.